Each vial is tested to confirm purity and identity
H tr qu trnh thanh lc c th, loi b cc c t v kim loi nng khi c th
On one hand, we have the most effective and potentially scalable intervention to the most common chronic disease in the world
Data show that in adult patients with type 2 diabetes with increased cardiovascular (CV) risk, compared with titrated insulin glargine, all three doses of tirzepatide show superiority in reducing blood sugar and body weight: treatment for 52 weeks, with curative effect Estimation (efficacy estimand) statistical analysis method, the highest dose of tirzepatide (15 mg, once a week) reduces blood glucose level (A1C) from baseline by 2.58%, and weight from baseline by 11.7 kg (25.8 pounds, 13.0%), and titration Insulin glargine reduced A1C from baseline by 1.44% and body weight increased by 1.9 kg (4.2 lbs, 2.2%) from baseline
But potential future changes, such as the World Health Organization (WHO) designating liraglutide an essential medicine in the 2025 update to the EML, could tip the balance towards cost effectiveness